Substances
About Database
Substances
About Database
In this article, you will learn about the structure and purpose of the Proresilients and Cellular Chronoblockers database
The electronic database of proresilients and cellular chronoblockers accumulates information on the composition, mechanisms of action, and level of evidence for substances, agents, and technologies that prevent proxy diseases of aging, their complications, and improve adaptation and quality of life.
Today, we live longer than ever before — and more people are asking not just how to live longer, but how to stay active, healthy, and clear-minded as they age. Aging is increasingly seen not as an inevitability, but as a process that can be influenced.
Over the past years, a growing body of research has emerged on substances that support resilience and slow down age-related decline — but this information is often scattered and hard to navigate.
This database was created as a response — a living, evolving resource with expert-reviewed content, scientific annotations, and intuitive navigation through products and substances linked to healthy longevity.
The Proresilients and Cellular Chronoblockers database is led and scientifically coordinated by the Open Institute of Age and Aging (Serbia).
Expert contributors from partner academic and medical institutions evaluate submitted substances and products, review the supporting evidence, and assign statuses within the database, including Masaryk University (MUNI), I.K. Akhunbaev Kyrgyz State Medical Academy, Universidad Estatal Península de Santa Elena (UPSE), Tel Aviv University, Vitebsk State Order of Peoples’ Friendship Medical University, and the Academician Abdulla Karayev Institute of Physiology.
Manufacturers of anti-aging products (or those with potential anti-aging effects) can submit applications for inclusion. A decision on assigning one of the official statuses is made by an international expert commission, based on the portal’s evaluation methodology.